Shopping Cart 0
Cart Subtotal
USD 0

Dexcel PT Israel Ltd - Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Dexcel PT Israel Ltd-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Dexcel PT Israel Ltd (Dexcel Pharma), a subsidiary of Dexcel PT Holdings Ltd develops, manufactures and markets branded and generic pharmaceuticals in various dosage forms. Its major products include PerioChip (chlorhexidine gluconate), a non-antibiotic adjunct treatment for scaling and root planning and adult periodontitis; Deximune, an immunosuppressant; and omeprazole delayed released tablet for the treatment of gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome. It also offers products for allergy, pain relief, cardiovascular disorders, dental diseases, and skin diseases, among others. Dexcel Pharma develops formulations using proprietary, patent-protected, drug delivery technologies. It sells its products through a network of subsidiaries, distributors in Western Europe. Dexcel Pharma is headquartered in Or Akiva, Haifa, Israel.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Dexcel PT Israel Ltd-Key Facts

Dexcel PT Israel Ltd-Key Employees

Dexcel PT Israel Ltd-Key Employee Biographies

Dexcel PT Israel Ltd-Major Products and Services

Dexcel PT Israel Ltd-History

Dexcel PT Israel Ltd-Company Statement

Dexcel PT Israel Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Dexcel PT Israel Ltd-Business Description

Dexcel PT Israel Ltd-SWOT Analysis

SWOT Analysis-Overview

Dexcel PT Israel Ltd-Strengths

Dexcel PT Israel Ltd-Weaknesses

Dexcel PT Israel Ltd-Opportunities

Dexcel PT Israel Ltd-Threats

Dexcel PT Israel Ltd-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Dexcel PT Israel Ltd, Recent Deals Summary

Section 4-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Dexcel PT Israel Ltd, Key Facts

Dexcel PT Israel Ltd, Key Employees

Dexcel PT Israel Ltd, Key Employee Biographies

Dexcel PT Israel Ltd, Major Products and Services

Dexcel PT Israel Ltd, History

Dexcel PT Israel Ltd, Other Locations

Dexcel PT Israel Ltd, Subsidiaries

Dexcel PT Israel Ltd, Key Competitors

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Dexcel PT Israel Ltd, Recent Deals Summary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Dexcel PT Israel Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Teva Pharmaceutical Industries Ltd

RedHill Biopharma Ltd

Rafa Laboratories Ltd

PainReform Ltd

Kamada Ltd

Foamix Pharmaceuticals Ltd

Company Profile

Company Profile Title

Dexcel PT Israel Ltd-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Dexcel PT Israel Ltd (Dexcel Pharma), a subsidiary of Dexcel PT Holdings Ltd develops, manufactures and markets branded and generic pharmaceuticals in various dosage forms. Its major products include PerioChip (chlorhexidine gluconate), a non-antibiotic adjunct treatment for scaling and root planning and adult periodontitis; Deximune, an immunosuppressant; and omeprazole delayed released tablet for the treatment of gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome. It also offers products for allergy, pain relief, cardiovascular disorders, dental diseases, and skin diseases, among others. Dexcel Pharma develops formulations using proprietary, patent-protected, drug delivery technologies. It sells its products through a network of subsidiaries, distributors in Western Europe. Dexcel Pharma is headquartered in Or Akiva, Haifa, Israel.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Dexcel PT Israel Ltd-Key Facts

Dexcel PT Israel Ltd-Key Employees

Dexcel PT Israel Ltd-Key Employee Biographies

Dexcel PT Israel Ltd-Major Products and Services

Dexcel PT Israel Ltd-History

Dexcel PT Israel Ltd-Company Statement

Dexcel PT Israel Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Dexcel PT Israel Ltd-Business Description

Dexcel PT Israel Ltd-SWOT Analysis

SWOT Analysis-Overview

Dexcel PT Israel Ltd-Strengths

Dexcel PT Israel Ltd-Weaknesses

Dexcel PT Israel Ltd-Opportunities

Dexcel PT Israel Ltd-Threats

Dexcel PT Israel Ltd-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Dexcel PT Israel Ltd, Recent Deals Summary

Section 4-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Dexcel PT Israel Ltd, Key Facts

Dexcel PT Israel Ltd, Key Employees

Dexcel PT Israel Ltd, Key Employee Biographies

Dexcel PT Israel Ltd, Major Products and Services

Dexcel PT Israel Ltd, History

Dexcel PT Israel Ltd, Other Locations

Dexcel PT Israel Ltd, Subsidiaries

Dexcel PT Israel Ltd, Key Competitors

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Dexcel PT Israel Ltd, Recent Deals Summary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Dexcel PT Israel Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Teva Pharmaceutical Industries Ltd

RedHill Biopharma Ltd

Rafa Laboratories Ltd

PainReform Ltd

Kamada Ltd

Foamix Pharmaceuticals Ltd